Cyduct Diagnostics Inc (CYDX)
Cyduct Diagnostics Inc. is a healthcare company listed on OTC Markets as common stock under the symbol CYDX. The company develops, manufactures, and markets medical devices focused on breast cancer assessment, identification, diagnosis, and treatment. Its product lineup includes the HALO system, a noninvasive device designed to collect breast fluid using proprietary technology, and MammoView, a fiberoptic technology used to view and collect cells and other abnormalities. Cyduct Diagnostics also promotes intraductal approaches intended to support breast healthcare for women and clinicians. The company was incorporated in 1986 and is based in Westport, Connecticut. It operated previously under the name Solos Endoscopy, Inc. before adopting its current name in December 2020.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-CYDX
|
—
|
—
|
—
|
—
|
—
|
—
|
Excellent
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
14.15 M
|
—
|
—
|
—
|
—
|
—
|
—
|
